UMUl'YAna S. Malyavina

Ul'YAna S. Malyavina

*This is an algorithmically generated author record based on publicly available information.

Ul'YAna S. Malyavina has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cholestaetoma of the frontal sinus in a child

    by U.S. Malyavina, Yu.YU. Rusetsky, E.N. Latysheva, A.N. Bershina

    Cholesteatoma is a relatively common disease of the middle ear and mastoid process, but is rare in the paranasal sinuses. Among the paranasal sinusis, the frontal sinus is the most common location. Given the rarity of localization, there is no consensus on treatment tactics. Maximum surgical removal of the formation is the only effective treatment method. However, the choice of optimal access and the need for intraoperative obliteration of the sinus remain a question. The article presents a rare clinical case of frontal sinus cholesteatoma in a child with successful surgical treatment using osteoplastic obliteration of the sinus.

  • Open Access

    Hearing disorders in children with muco-obstructive lung diseases

    by Vera N. Sokolova, Ulyana S. Malyavina, Olga I. Simonova, Dmitriy S. Kondratchikov, В. Н. Соколова, У. С. Малявина, О. И. Симонова, Д. С. Кондратчиков

    Introduction. Cystic fibrosis (CF) primary ciliary dyskinesia are hereditary diseases characterized by impaired mucociliary clearance and chronic respiratory tract involvement. Aim. To present current literature data on the pathogenesis of hearing loss in muco-obstructive lung diseases and detect risks of aminoglycoside ototoxicity under the modulating therapy for CF in children. There was performed an analysis of scientific literature data from international databases (Scopus, Web of Science, PubMed) and Russian scientific libraries (eLIBRARY.RU, CyberLeninka). Differences in the nature of hearing loss in СF and primary ciliary dyskinesia were established. For the primary ciliary dyskinesia there is characteristic hearing loss, whereas in CF the risk of sensorineural hearing loss persists due to the ototoxicity of aminoglycosides caused by targeted therapy. Personalized treatment and prevention of these forms of pathology in children help reduce risks, necessitating the development of specialized monitoring algorithms. The need for a differentiated approach to monitoring auditory function in patients with muco-obstructive lung diseases has been established. Contributions: Sokolova V.N. — concept and design of the study; Sokolova V.N., Malyavina U.S., Simonova O.I. — material collection and processing; Sokolova V.N., Malyavina U.S. — writing the text; Simonova O.I., Kondratchikov D.S. — editing the text. All authors approved the final version of the manuscript and are responsible for the integrity of all parts of the article. Acknowledgments. The study had no sponsorship. Conflict of interest. The authors declare no conflict of interest. Received: January 23, 2026 Accepted: February 10, 2026 Published: February 27, 2026

  • Open Access

    Rare presentations of otodystrophies of the temporal bone (a review and case report)

    by Ulyana S. Malyavina, Aleksandra E. Pashkova, Larisa S. Sotnikova, Aleksandr V. Pashkov, Малявина Ульяна Станиславовна

    Otodystrophies represent a group of disorders affecting the temporal bone in addition to involvement of other skeletal structures and may lead to conductive, sensorineural (neurosensory), or mixed hearing loss. Conductive hearing loss results from inflammatory involvement of the external auditory canal, ossicular chain, or oval window. Sensorineural hearing loss occurs due to involvement of the otic capsule or internal auditory canal. The etiology of otodystrophies may be metabolic, genetic, or unknown. The most common form of otodystrophy is otosclerosis. However, considerably rarer manifestations are also encountered in clinical practice, including osteopetrosis, osteogenesis imperfecta, fibrous dysplasia, and Paget disease of bone. These conditions are frequently underdiagnosed in the setting of systemic skeletal involvement. Osteopetrosis is a rare hereditary disorder characterized by generalized excessive bone formation, leading to bone thickening and narrowing or even complete obliteration of bone marrow spaces. Osteogenesis imperfecta is an inherited connective tissue disorder caused by a defect in the primary collagen structure or insufficient collagen synthesis due to mutations in the COL1A and COL1A2 genes. Fibrous dysplasia is a slowly progressive benign fibro-osseous disorder in which normal bone tissue is replaced by fibrous tissue, resulting in bone deformity. Paget disease of bone is a non-inflammatory metabolic skeletal disorder characterized by focal hyperactivity of osteoclasts, resulting in formation of coarse, structurally weakened, demineralized, and hypervascular bone tissue. Awareness of these conditions, their differential diagnostic features, and therapeutic approaches is particularly important for clinical practice. This article presents clinical observations of rare otodystrophy presentations involving the temporal bone. A review of the sceintific data on the diagnosis and management of these disorders is presented. In addition, a clinical case of a 12-year-old girl with clinical features of one of the rare otodystrophy variants—osteopetrosis—is described. Clinical manifestations and computed tomography findings of the temporal bone were confirmed by genetic testing.

  • Exoscopic visualisation with VITOM® 3D in paediatric cochlear implantation: Preliminary results

    by Yury Rusetsky, Natalia Chuchueva, Irina Meytel, Uliana Malyavina, Seitmurat Farikov


  • Open Access

    Cochlear Implantation in a Child With Hypoplastic Left-heart Syndrome: Clinical Case

    by Margarita S. Kalugina, Yuri Yu. Rusetskiy, Andrei E. Aleksandrov, Aleksandr V. Pashkov, Ul'YAna S. Malyavina, Elena A. Alekseeva, Ю. Ю. Русецкий, У. С. Малявина

    Кохлеарная имплантация у ребенка с синдромом гипоплазии левых отделов сердца:клинический случай